Targeting Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Emerging Role of GLP-1 Receptor Agonists Posted on 06/08/202607/08/2026 by admin ACHAIKI IATRIKI | 2026; 45(2): 66–68 Editorial Maria Kalafateli Continue reading “Targeting Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Emerging Role of GLP-1 Receptor Agonists” →